Applied Therapeutics Stock Story

APLT Stock  USD 6.88  0.03  0.44%   
Slightly above 53% of Applied Therapeutics' private investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Applied Therapeutics suggests that some traders are interested. Applied Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Applied Therapeutics. The current market sentiment, together with Applied Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Applied Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Applied Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Applied daily returns and investor perception about the current price of Applied Therapeutics as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Applied Therapeutics.

Applied Therapeutics Latest Timeline

Applied Therapeutics is listed for 6.88. The company currently holds 1.23 M in liabilities with Debt to Equity (D/E) ratio of 0.14, which may suggest the company is not taking enough advantage from borrowing. Applied Therapeutics has a current ratio of 1.46, which is within standard range for the sector. Debt can assist Applied Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Applied Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Applied Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Applied to invest in growth at high rates of return. When we think about Applied Therapeutics' use of debt, we should always consider it together with cash and equity.
When determining whether Applied Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Applied Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Applied Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Applied Therapeutics Stock:
Check out Applied Therapeutics Hype Analysis, Applied Therapeutics Correlation and Applied Therapeutics Performance.
For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Applied Stock analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Managers
Screen money managers from public funds and ETFs managed around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Is Applied Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied Therapeutics. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.42)
Revenue Per Share
0.119
Return On Assets
(0.87)
Return On Equity
(6.82)
The market value of Applied Therapeutics is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Applied Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied Therapeutics' market value can be influenced by many factors that don't directly affect Applied Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.